Acquisitions and Collaborations (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended				12 Months Ended		12 Months Ended		12 Months Ended				12 Months Ended				12 Months Ended					12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 SkinMedica Acquisition [Member]	Dec. 19, 2012 SkinMedica Acquisition [Member]	Dec. 31, 2012 SkinMedica Acquisition [Member] Developed Technology [Member]	Dec. 19, 2012 SkinMedica Acquisition [Member] Developed Technology [Member]	Dec. 31, 2012 SkinMedica Acquisition [Member] Customer Relationships [Member]	Dec. 19, 2012 SkinMedica Acquisition [Member] Customer Relationships [Member]	Dec. 31, 2012 SkinMedica Acquisition [Member] Trademarks [Member]	Dec. 19, 2012 SkinMedica Acquisition [Member] Trademarks [Member]	Dec. 31, 2012 Purchase of Distributors Business In Russia [Member]	Feb. 01, 2012 Purchase of Distributors Business In Russia [Member]	Dec. 31, 2012 Purchase of Distributors Business In Russia [Member] Customer Relationships [Member]	Dec. 31, 2012 Purchase of Distributors Business In Russia [Member] Contractual Rights [Member]	Dec. 31, 2012 Precision Light Acquisition [Member]	Aug. 08, 2011 Precision Light Acquisition [Member]	Dec. 31, 2012 Precision Light Acquisition [Member] Distribution Rights [Member]	Aug. 08, 2011 Precision Light Acquisition [Member] Distribution Rights [Member]	Dec. 31, 2012 Vicept Acquisition [Member]	Jul. 22, 2011 Vicept Acquisition [Member]	Jun. 30, 2011 Purchase of Distributors Business In South Africa [Member]	Dec. 31, 2012 Purchase of Distributors Business In South Africa [Member] Distribution Rights [Member]	Jun. 30, 2011 Purchase of Distributors Business In South Africa [Member] Distribution Rights [Member]	Jun. 17, 2011 Alacer Acquisition [Member]
Business Acquisition [Line Items]
Aggregate purchase price of acquisition, net of cash																					$ 8.6			$ 7.0
Purchase price paid in cash				346.1								3.1				11.7				74.1
Payments contingent upon achieving certain future milestones				25.0																200.0
Pre-existing receivable from the distributor												6.6									2.2
Estimated fair value of the contingent consideration as of the acquisition date				2.2								4.7				6.2				163.0
Fair value of assets acquired				424.5								14.4				28.0				343.8	11.1			12.3
Current assets				30.2
Intangible assets				198.6																				9.0
Amortizable intangible assets						87.1		50.6		60.6		8.6						20.2					3.9
Deferred tax assets				46.4
Deferred tax assets - non-current																1.2				7.6				1.0
In-process research and development asset				0.3																287.0
Inventories												2.0									5.6
Goodwill				142.7								3.8				6.6				49.2	1.6			2.3
Property, plant and equipment				6.6
Liabilities assumed				76.2												10.1				106.7				5.3
Current liabilities				11.3												2.6				2.3
Accrued liabilities																					0.3			2.0
Deferred tax liabilities - non-current				64.9												7.5				104.4				3.3
Estimated useful life of the intangible asset	12 years 6 months	12 years 7 months			10 years 7 months		2 years 8 months		15 years				3 years	2 years			5 years					10 years
Estimated fair value of the contingent consideration	224.3	214.6									4.9				6.9				160.0
Estimated fair value of the contingent consideration recorded in other accrued expenses	59.0	4.9									3.0				1.0				49.8
Estimated fair value of the contingent consideration recorded in other liabilities	$ 165.3	$ 209.7	$ 2.2								$ 1.9				$ 5.9				$ 110.2